This content is provided by Chambers. Learn more about our methodology
What the team is known for Market-leading array of expert regulatory teams offering a strong grasp of the environment, life sciences, agriculture and food sectors. Further noted for its expertise advising on public affairs. Represents clients in novel EU environmental regulations including the restriction of microplastics and the newly adopted Directive on Single-Use Plastic Products, as well as EU emissions trading and REACH authorisations. World-renowned teams in London and Brussels act for life sciences clients on the full range of regulatory matters, including the orphan medicines system and clinical trials. Acts for food producers and retailers on food safety requirements, advertising regulations and GMO products. Benefits from a pre-eminent public policy team with Brussels-based team members representing clients in their engagement with EU institutions regarding legislative developments, while teams in London advise on UK policy and engagement.
Strengths Clients describe the firm as "a one-stop shop," offering "a really broad range of advice."
Another praises the firm's depth of knowledge, describing the advice as "very good, very detailed and always accurate," and adding that the lawyers "always seem to know where to refer back to."
Work highlights Advised the Biomanufacturing Alliance on the drafting of comments on the ECA's proposals to restrict microplastics.
Brian Kelly is reputed for his extensive experience advising on food law. He is particularly active advising on supplements and novel food products, assisting with labelling and advertisements. Clients praise his ability to "think outside the box." Another source enthuses: "You would definitely want him in your corner for any contentious matter."
Cándido García Molyneux advises on a range of novel EU regulations, including proposed restrictions on microplastics and the Directive on Single-Use Plastic Products, as well as REACH classifications. A client enthuses: "If you want a legal opinion as close to what the courts, board of appeal or regulators will come up with, he is just the best."
Grant Castle for being "really steeped in life sciences," noting that he "understands the industry very well and has a lot of practical experience." He acts for a range of pharmaceutical companies and trade associations on Brexit contingency planning, as well as the marketing of products and clinical trials.
"King of life sciences" and "extremely capable,"
Peter Bogaert is revered for his wide-ranging regulatory expertise. He represents leading multinational life sciences clients in matters relating to pharmacovigilance and good manufacturing practice, as well as potential Brexit outcomes.
Sebastian Vos is well regarded for his practice assisting clients with negotiations and interactions with EU institutions. He advises on trade policy, the digital single market and policy monitoring.